Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer (RE-NEZ-SENS)
Sponsor: University Hospital, Montpellier
Terminated
Enrolement difficulties
Other terminated trials from University Hospital, Montpellier
This NA trial investigates Haematological Cancer and Lymphoma and is currently terminated or withdrawn. University Hospital, Montpellier leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2025 — Feb 2026 [monthly]
Recruiting NA
-
Jun 2025 — Jul 2025 [monthly]
Recruiting NA
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2022 — Mar 2024 [monthly]
Recruiting NA
-
Sep 2021 — Jan 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .